Targiniq ER (naloxone / oxycodone) Drug Interactions
A total of 482 drugs are known to interact with Targiniq ER (naloxone / oxycodone).
- 178 major drug interactions
- 302 moderate drug interactions
- 2 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Targiniq ER (naloxone / oxycodone) and the medicines listed below.
- amitriptyline
- aspirin
- Celebrex (celecoxib)
- cholecalciferol
- diazepam
- Endep (amitriptyline)
- Lyrica (pregabalin)
- metformin
- metoclopramide
- mirtazapine
- oxycodone
- Panadol Osteo (acetaminophen)
- pantoprazole
- Paracetamol (acetaminophen)
- pregabalin
- Seroquel (quetiapine)
- tapentadol
- temazepam
- tramadol
- Valium (diazepam)
Targiniq ER (naloxone / oxycodone) alcohol/food interactions
There is 1 alcohol/food interaction with Targiniq ER (naloxone / oxycodone)
Targiniq ER (naloxone / oxycodone) disease interactions
There are 21 disease interactions with Targiniq ER (naloxone / oxycodone) which include:
- CV disorders
- impaired GI motility
- infectious diarrhea
- liver disease
- prematurity
- acute alcohol intoxication
- drug dependence
- gastrointestinal obstruction
- hypotension
- intracranial pressure
- respiratory depression
- liver disease
- renal
- septic shock
- adrenal insufficiency
- biliary spasm
- hypothyroidism
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
More about Targiniq ER (naloxone / oxycodone)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- 1 Review
- Drug class: narcotic analgesic combinations
- FDA Approval History
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
